ABEO ABEONA THERAPEUTICS INC.

8-K Current Report

Filed: March 9, 2026

Health Care

Pharmaceutical Preparations

ABEONA THERAPEUTICS INC. (ABEO) 8-K current report filed with SEC EDGAR on March 9, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• ZEVASKYN commercial launch update signals early momentum in gene therapy product rollout
• Press release dated March 9, 2026 — suggests active commercialization phase underway for flagship product

+1 more insights

Other ABEONA THERAPEUTICS INC. 8-K Filings

8-K Mar 17, 2026

Get deeper insights on ABEONA THERAPEUTICS INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.